InvestorsHub Logo
Followers 38
Posts 5557
Boards Moderated 0
Alias Born 02/25/2011

Re: None

Tuesday, 10/25/2016 7:20:02 AM

Tuesday, October 25, 2016 7:20:02 AM

Post# of 423967
New study supports observation of EPA+ optimal Statin and synergies, and IMO bodes well for R-I


Impact of Adding Eicosapentaenoic Acid to Statin Therapy on Plasma Pentraxin 3 Level in Patients with Stable Coronary Artery Disease: A 6-Month, Randomized Controlled Study

http://link.springer.com/article/10.1007/s40256-016-0195-y
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News